Skip Navigation


European Heart Journal Advance Access originally published online on June 25, 2007
European Heart Journal 2007 28(14):1668-1669; doi:10.1093/eurheartj/ehm214
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/14/1668    most recent
ehm214v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gammage, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gammage, M. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

External cardioversion in patients with implanted cardiac devices: is there a problem?

Michael D. Gammage

Department of Cardiovascular Medicine, The Medical School, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK

Corresponding author. Tel: +44 121 697 8338; fax: +44 121 414 3713. E-mail address: m.d.gammage@bham.ac.uk

This editorial refers to ‘External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application’ by J.C. Manegold et al., on page 1731

The first 10% of the full text of this article appears below.

As the indications for implantable cardiac devices [pacemakers, cardioverter-defibrillators (ICDs), and cardiac resynchronization systems (CRT)] have been extended over the last decade, the need for elective external cardioversion (ECV) in patients with such devices and concurrent atrial fibrillation (AF) has also increased. In addition, the overall requirement for ECV has also been extended by the increasing age of the population in most developed countries and a more aggressive approach to the management of recent-onset and haemodynamically compromising AF.1

The use of ECV in patients with implanted devices has long been a cause for concern with regard to the potential for adverse effects on the generator and/or leads, with the result that this simple . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application
Johannes C. Manegold, Carsten W. Israel, Joachim R. Ehrlich, Gabor Duray, Dmitri Pajitnev, Florian T. Wegener, and Stefan H. Hohnloser
EHJ 2007 28: 1731-1738. [Abstract] [FREE Full Text]